NFKB1 and COVID-19: Inflammatory response pathways (NF-κB signaling pathway, IL-17 signaling pathway, and antigen processing and presentation pathway) and pentose phosphate pathway were upregulated in severe and critical COVID-19 patients (Figure 2).